Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study

RecruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

November 15, 2020

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2025

Conditions
Chronic Graft-versus-Host-DiseaseLeukemiaAllogeneic Hematopoietic Stem Cell TransplantationBlood CancerNon-Malignant Hematologic and Lymphocytic Disorder
Trial Locations (16)

10174

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

14263

RECRUITING

Roswell Park Comprehensive Care Center, Buffalo

27599

NOT_YET_RECRUITING

University of North Carolina, Chapel Hill

28203

RECRUITING

Atrium Health Levine Cancer Institute, Charlotte

30322

NOT_YET_RECRUITING

Emory University School of Medicine, Atlanta

63110

NOT_YET_RECRUITING

Washington University School of Medicine, St Louis

80045

RECRUITING

Children's Hospital Colorado, Denver

94158

RECRUITING

University of California San Francisco, San Francisco

43205-2664

RECRUITING

Nationwide Children's Hospital, Columbus

97239-3098

RECRUITING

Oregon Health & Science University Knight Cancer Institute, Portland

37232-6311

RECRUITING

Vanderbilt University Medical Center, Nashville

T3B 6A8

RECRUITING

Alberta Children's Hospital, Calgary

V6H 3N1

RECRUITING

BC Children's Hospital, Vancouver

R3E 0V9

ACTIVE_NOT_RECRUITING

CancerCare Manitoba, Winnipeg

H3T 1C5

RECRUITING

CHU Sainte-Justine, Montreal

H4A 3J1

RECRUITING

McGill University Health Centre, Montreal

All Listed Sponsors
lead

University of British Columbia

OTHER